Tonix Pharmaceuticals Holding Corp. (TNXP)
NASDAQ: TNXP · Real-Time Price · USD
15.65
-0.12 (-0.76%)
Mar 20, 2026, 2:50 PM EDT - Market open

TNXP Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
207.6498.7824.95120.23178.66
Cash & Short-Term Investments
207.6498.7824.95120.23178.66
Cash Growth
110.21%295.93%-79.25%-32.70%131.82%
Accounts Receivable
6.273.68---
Inventory
6.018.4113.64--
Other Current Assets
--9.1810.5510.39
Total Current Assets
219.92110.8747.77130.78189.05
Net Property, Plant & Equipment
4642.8294.8594.5351.47
Other Intangible Assets
0.120.129.740.12-
Goodwill
--0.97--
Other Long-Term Assets
2.180.951.130.260.38
Total Assets
277.17162.89154.46225.69240.9
Accounts Payable
8.114.553.788.0713.28
Accrued Expenses
22.610.6712.489.687.95
Short-Term Debt
-2.822.35--
Current Portion of Leases
0.130.270.270.430.49
Total Current Liabilities
30.8418.3118.8818.1821.72
Long-Term Debt
-4.676.56--
Long-Term Leases
1.180.360.630.330.47
Other Long-Term Liabilities
--22.86--
Total Long-Term Liabilities
1.185.0330.050.330.47
Total Liabilities
32.0223.3348.9318.5122.18
Common Stock
0.010-0.010.02
Additional Paid-in Capital
1,100870.5706.42677.38578.61
Accumulated Other Comprehensive Income
-0.29-0.26-0.23-0.17-0.09
Retained Earnings
-854.72-730.69-600.66-470.04-359.82
Shareholders' Equity
245.15139.56105.53207.18218.72
Total Liabilities & Equity
277.17162.89154.46225.69240.9
Total Debt
1.318.129.810.760.96
Net Cash (Debt)
206.3390.6615.14119.47177.7
Net Cash Growth
127.59%498.99%-87.33%-32.77%134.57%
Net Cash Per Share
24.24123.121909.7865446.25312108.89
Book Value
245.15139.56105.53207.18218.72
Book Value Per Share
28.80189.5313315.46113496.26384141.71
Tangible Book Value
245.03139.4494.82207.06218.72
Tangible Book Value Per Share
28.79189.3711964.29113430.53384141.71
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q